BioMed's InPouch TV provides a streamlined approach for collecting and culturing Trichomonas vaginalis from both female and male samples. Combine cost-efficiency with precision for your lab's diagnostic needs. Learn more: https://hubs.ly/Q02RjYLm0 #culturemedia #culturediagnostics #Trichomonasvaginalis
Biomed Diagnostics, a DCN Dx Brand.
Medical Equipment Manufacturing
White City, Oregon 564 followers
Creators of the InTray and InPouch Diagnostic tools
About us
Biomed Diagnostics (A DCN Dx Brand) First conceived in 1989, Biomed Diagnostics is the resulting collaboration of two physicians who found themselves vulnerable without the necessary equipment during a mercy mission in Central America. Without the necessary refrigeration, practical supplies and laboratory instrumentation to identify which organisms were causing illness in local residents, they set about researching and developing innovative point of care devices with could be easily packaged and contained. Their efforts over a 7-year pursuit culminated in the first InPouch® and InTray® culture systems. These fully enclosed tools provided an in-field solution to human and animal infections in third-world countries, ranches and rural communities. In 1996 the patents were obtained by Robert Hall and Jane Hall, the founding partners of Biomed Diagnostics. Specimen collection, culturing and transport could now be done in a single device - allowing medical professionals to accurately detect and differentiate various pathogens. Today, Biomed honors our origins and is dedicated to combating health threats around the globe by providing the CDC and global health organizations tools in the surveillance of antibiotic-resistant causing microorganisms.
- Website
-
www.biomeddiagnostics.com
External link for Biomed Diagnostics, a DCN Dx Brand.
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- White City, Oregon
- Type
- Privately Held
- Founded
- 1989
- Specialties
- IVD, microbiology, and culture diagnostics
Locations
-
Primary
Get directions
1388 Antelope Rd
White City, Oregon 97503, US
Employees at Biomed Diagnostics, a DCN Dx Brand.
Updates
-
Our parent company, DCN Dx, will be exhibiting at MEDICA in Düsseldorf, Germany, from Nov. 11-14, 2024! Visit DCN's team of experts at our booth D25-2 in Hall 3 to explore their IVD CDMO and CRO services— including lateral flow assay development, industrial product design and device engineering, clinical research, and manufacturing. At the DCN Dx booth, attendees can also experience the miniDxR, a state-of-the-art customizable lateral flow assay reader. Designed by DCN Dx as an extension of its contract lateral flow assay development services, the miniDxR offers advanced imaging technology, superior sensitivity and specificity, and robust cybersecurity features—ideal for point-of-care testing. Request a meeting with DCN Dx at MEDICA: https://hubs.ly/Q02T98fw0 We also welcome you to attend DCN Dx's talk on "Navigating U.S. Market Entry: Leveraging IVD Service Providers for Compliance and Device Integration," presented by Dr. Patrick Vaughan, Ph.D., COO of DCN Dx. The event will take place Nov. 11, 11:45 a.m. - 12:05 p.m. local time, in Hall 8A, Booth G40. We look forward to seeing you there! #MEDICA #MEDICA2024 #LateralFlow #LFA #AssayDevelopment #IVDCRO #IVDCDMO #DiagnosticsDevelopment #RapidTesting #RapidTest #Immunoassay #POCT #ClinicalResearch
-
-
In a recent article from our parent company DCN Dx's Expert Insights series, Dr. Pat Vaughan, COO at DCN Dx, shares 7 practical strategies for designing high-performance lateral flow assays (LFAs) for low- and middle-income countries (LMICs). Learn how to balance affordability, sensitivity, and scalability while avoiding common pitfalls. This guide is essential for developers who want to create reliable, scalable diagnostics that improve healthcare outcomes in even the most resource-limited settings. 👉 Read the full article by Dr. Pat Vaughan on our website: https://hubs.ly/Q02TL1gg0 #ExpertInsights #GlobalHealth #Diagnostics #LateralFlow #LateralFlowAssay #RapidTest #HealthcareInnovation #IVD #LMIC #WHO #POCT #MedicalDevices #DCNDx
-
-
Our parent company, DCN Dx, will be exhibiting at MEDICA in Düsseldorf, Germany, from Nov. 11-14, 2024! Visit DCN's team of experts at our booth D25-2 in Hall 3 to explore their IVD CDMO and CRO services— including lateral flow assay development, industrial product design and device engineering, clinical research, and manufacturing. At the DCN Dx booth, attendees can also experience the miniDxR, a state-of-the-art customizable lateral flow assay reader. Designed by DCN Dx as an extension of its contract lateral flow assay development services, the miniDxR offers advanced imaging technology, superior sensitivity and specificity, and robust cybersecurity features—ideal for point-of-care testing. Request a meeting with DCN Dx at MEDICA: https://hubs.ly/Q02T999g0 We also welcome you to attend DCN Dx's talk on "Navigating U.S. Market Entry: Leveraging IVD Service Providers for Compliance and Device Integration," presented by Dr. Patrick Vaughan, Ph.D., COO of DCN Dx. The event will take place Nov. 11, 11:45 a.m. - 12:05 p.m. local time, in Hall 8A, Booth G40. We look forward to seeing you there! #MEDICA #MEDICA2024 #LateralFlow #LFA #AssayDevelopment #IVDCRO #IVDCDMO #DiagnosticsDevelopment #RapidTesting #RapidTest #Immunoassay #POCT #ClinicalResearch
-
-
BioMed's InPouch TV provides a streamlined approach for collecting and culturing Trichomonas vaginalis from both female and male samples. Combine cost-efficiency with precision for your lab's diagnostic needs. Learn more: https://hubs.ly/Q02Qypq-0 #BiomedDiagnostics #DCNDx #CultureDiagnostics #Microbiology #Diagnostics #TrichomonasVaginalis #InPouch
-
-
InTray VS COLOREX isn't only for urinary tract pathogen detection. It's a versatile tool capable of differentiating a range of microorganisms across various infection sites. Learn more: https://hubs.ly/Q02QycT-0
-
-
BioMed's InPouch TV provides a streamlined approach for collecting and culturing Trichomonas vaginalis from both female and male samples. Combine cost-efficiency with precision for your lab's diagnostic needs. Learn more: https://hubs.ly/Q02Rj_v60 #culturemedia #culturediagnostics #Trichomonasvaginalis
-
-
In a recent article from our parent company DCN Dx's Expert Insights series, Dr. Pat Vaughan, COO at DCN Dx, shares 7 practical strategies for designing high-performance lateral flow assays (LFAs) for low- and middle-income countries (LMICs). Learn how to balance affordability, sensitivity, and scalability while avoiding common pitfalls. This guide is essential for developers who want to create reliable, scalable diagnostics that improve healthcare outcomes in even the most resource-limited settings. 👉 Read the full article by Dr. Pat Vaughan on our website: https://hubs.ly/Q02TL1y40 #ExpertInsights #GlobalHealth #Diagnostics #LateralFlow #LateralFlowAssay #RapidTest #HealthcareInnovation #IVD #LMIC #WHO #POCT #MedicalDevices #DCNDx
-
-
Simplify your diagnostic steps by combining inoculation, culture, transport, and result into a single device. BioMed's all-in-one #DiagnosticTesting devices are available now: https://hubs.ly/Q02QynPR0 #CultureDiagnostics #IVD #BioMedDiagnostics
-
-
Our parent company, DCN Dx, will be exhibiting at MEDICA in Düsseldorf, Germany, from Nov. 11-14, 2024! Visit DCN's team of experts at our booth D25-2 in Hall 3 to explore their IVD CDMO and CRO services— including lateral flow assay development, industrial product design and device engineering, clinical research, and manufacturing. At the DCN Dx booth, attendees can also experience the miniDxR, a state-of-the-art customizable lateral flow assay reader. Designed by DCN Dx as an extension of its contract lateral flow assay development services, the miniDxR offers advanced imaging technology, superior sensitivity and specificity, and robust cybersecurity features—ideal for point-of-care testing. Request a meeting with DCN Dx at MEDICA: https://hubs.ly/Q02T96Xh0 We also welcome you to attend DCN Dx's talk on "Navigating U.S. Market Entry: Leveraging IVD Service Providers for Compliance and Device Integration," presented by Dr. Patrick Vaughan, Ph.D., COO of DCN Dx. The event will take place Nov. 11, 11:45 a.m. - 12:05 p.m. local time, in Hall 8A, Booth G40. We look forward to seeing you there! #MEDICA #MEDICA2024 #LateralFlow #LFA #AssayDevelopment #IVDCRO #IVDCDMO #DiagnosticsDevelopment #RapidTesting #RapidTest #Immunoassay #POCT #ClinicalResearch
-